# A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)

> **NCT03924154** · PHASE2 · TERMINATED · sponsor: **Altavant Sciences GmbH** · enrollment: 3 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** RVT-1201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03924154
- **Lead sponsor:** Altavant Sciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-02-24
- **Final completion:** 2020-02-24
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Inability to enroll
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03924154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03924154, "A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03924154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*